Haemonetics Shares Rise On Supply Agreement With CSL Plasma
Dow Jones2026/08/18 14:58By Anvee Bhutani
Haemonetics shares rose in Tuesday morning trading after the company said it entered into a supply agreement with CSL Plasma for its NexSys PCS devices and related disposables in the U.S.
Shares of the company were recently up 15% at $104.22.
Under the non-exclusive agreement, CSL may use Haemonetics' NexSys PCS devices with Persona PLUS technology and purchase related disposables.
Haemonetics expects CSL to transition a portion of its U.S. plasma-collection centers to the devices, though the scope and timing of the rollout have not yet been determined. The agreement doesn't include minimum purchase commitments.
Haemonetics said it isn't updating its fiscal 2027 guidance at this time and expects to provide an update on the agreement's anticipated impact on results during its fiscal second-quarter earnings call in November.
Write to Anvee Bhutani at anvee.bhutani@wsj.com
(END) Dow Jones Newswires
August 18, 2026 10:58 ET (14:58 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The “outlier” in the AI capital expenditure frenzy: Apple (AAPL.US) keeps spending flat, accounting for less than 5% of sales
Apple continues to stand out among major tech peers, largely avoiding the aggressive wave of capital expenditure associated with artificial intelligence (AI) infrastructure.
Youth Employment Declines for 48 Consecutive Months: Behind the Semiconductor Boom, Young South Koreans Are Being Left Behind by the Times
In South Korea, the unemployment rate in October fell to a three-year low of 2.5%. However, the number of employed people decreased by 50,000, youth employment has declined for 48 consecutive months, and domestic demand remains weak.
Strategy (MSTR.US) Faces Potential Removal from MSCI Index, Passive Funds May Sell $2.8 Billion
MicroStrategy is expected to be removed from the MSCI Global Investable Market Index. JPMorgan estimates that passive funds may sell about $2.8 billion worth of shares, and if removed from multiple indexes simultaneously, the scale could reach up to $8.8 billion. Additionally, with BTC falling below its average cost of $75,456, the company’s stock price and financing capacity are under dual pressure.
Crypto prices
More
